Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Spahn

Showing results (21-30 of 106) with videos related to

Pageof 11
Sort By:
European Urology|January 3, 2012
Nodal staging in prostate cancer: still an unresolved issueSteven Joniau, Laura Van den Bergh, Charlotte Peeters, et al.
Scandinavian Journal of Urology and Nephrology|February 28, 2012
Radical prostatectomy in very high-risk localized prostate cancer: long-term outcomes and outcome predictorsSteven Joniau, Chao-Yu Hsu, Paolo Gontero, et al.
Bone Marrow Transplantation|January 26, 2018
Response to first-line treatment and histology are associated with achieving complete remission after the first salvage high-dose chemotherapy in relapsing germ cell tumor patientsFlavio Gössi, Martin Spahn, Panagiotis Samaras, et al.
Advances in Urology|October 19, 2011
Sense and nonsense of an extended pelvic lymph node dissection in prostate cancerAnthony Van Baelen, Nicolas Mottet, Martin Spahn, et al.
Molecular and Cellular Endocrinology|February 13, 2017
Emerging aspects of microRNA interaction with TMPRSS2-ERG and endocrine therapyEugenio Zoni, Sofia Karkampouna, George N Thalmann, et al.
Urologic Oncology|August 2, 2011
Serum carcino-embryonic antigen (CEA) and its possible use as tumor marker for secondary tumors in urinary intestinal reservoirsAndreas Loeser, Michael Neumann, Arkardius Kocot, et al.
The Journal of Urology|September 21, 2010
Long-term results of a staged approach: continent urinary diversion in preparation for renal transplantationArkadius Kocot, Martin Spahn, Andreas Loeser, et al.
Current Urology Reports|August 13, 2015
What is the Need for Prostatic Biomarkers in Prostate Cancer Management?Martin Spahn, Silvan Boxler, Steven Joniau, et al.
Urologia Internationalis|February 23, 2010
The worst case: giant exulcerating seminomaMarkus Letsch, Martin Spahn, Matthias Beissert, et al.
European Urology Oncology|November 29, 2020
Newly Diagnosed Oligometastatic Prostate Cancer: Current Controversies and Future DevelopmentsNicola Fossati, Gianluca Giannarini, Steven Joniau, et al.
Pageof 11

Showing results (21-30 of 106) with videos related to

Sort By:
Pageof 11
European Urology|January 3, 2012
Nodal staging in prostate cancer: still an unresolved issueSteven Joniau, Laura Van den Bergh, Charlotte Peeters, et al.
Scandinavian Journal of Urology and Nephrology|February 28, 2012
Radical prostatectomy in very high-risk localized prostate cancer: long-term outcomes and outcome predictorsSteven Joniau, Chao-Yu Hsu, Paolo Gontero, et al.
Bone Marrow Transplantation|January 26, 2018
Response to first-line treatment and histology are associated with achieving complete remission after the first salvage high-dose chemotherapy in relapsing germ cell tumor patientsFlavio Gössi, Martin Spahn, Panagiotis Samaras, et al.
Advances in Urology|October 19, 2011
Sense and nonsense of an extended pelvic lymph node dissection in prostate cancerAnthony Van Baelen, Nicolas Mottet, Martin Spahn, et al.
Molecular and Cellular Endocrinology|February 13, 2017
Emerging aspects of microRNA interaction with TMPRSS2-ERG and endocrine therapyEugenio Zoni, Sofia Karkampouna, George N Thalmann, et al.
Urologic Oncology|August 2, 2011
Serum carcino-embryonic antigen (CEA) and its possible use as tumor marker for secondary tumors in urinary intestinal reservoirsAndreas Loeser, Michael Neumann, Arkardius Kocot, et al.
The Journal of Urology|September 21, 2010
Long-term results of a staged approach: continent urinary diversion in preparation for renal transplantationArkadius Kocot, Martin Spahn, Andreas Loeser, et al.
Current Urology Reports|August 13, 2015
What is the Need for Prostatic Biomarkers in Prostate Cancer Management?Martin Spahn, Silvan Boxler, Steven Joniau, et al.
Urologia Internationalis|February 23, 2010
The worst case: giant exulcerating seminomaMarkus Letsch, Martin Spahn, Matthias Beissert, et al.
European Urology Oncology|November 29, 2020
Newly Diagnosed Oligometastatic Prostate Cancer: Current Controversies and Future DevelopmentsNicola Fossati, Gianluca Giannarini, Steven Joniau, et al.
Pageof 11